clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Virtual Event
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Informatics
Alto Neuroscience Gets One Step Closer to Precision Depression Treatment
News & Features
Seattle Children’s CAR T Spinout BrainChild Bio Launches with a Focus…
News & Features
Texas Children’s Hospital Delivers First Gene Therapy for Rett Syndrome
News & Features
Separate Studies Show Why Some Prostate Cancers Become Resistant to Hormone…
Informatics
Generative AI Experts Absci Partner with AstraZeneca to Develop Cancer Treatment
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Virtual Event
Learning Labs
Podcasts
Inside Precision Medicine Live
Glaucoma
News & Features
More Evidence Found of Connection Between HSV-1 and Neurodegenerative Diseases
Chris Anderson
-
September 14, 2021
0
News & Features
Gene Therapy Developed in Mice Shows Promise For Treating Retinal Diseases
Sophia Ktori
-
July 23, 2021
0
News & Features
Polygenic Testing Can Improve Glaucoma Risk Prediction
Helen Albert
-
July 15, 2021
0
Molecular Dx
Novel Biomarker Could Aid Development of Drugs for Age-Related Disorders
Sophia Ktori
-
April 5, 2021
0
News & Features
New Gene Therapy Approach Could Repair Damage Caused by Glaucoma, Dementia
Sophia Ktori
-
April 1, 2021
0
News & Features
Researchers ID 40 Genes that Thwart Axon Regeneration in CNS Cells
Kevin Mayer
-
March 3, 2021
0
News & Features
Large Multi-Ethnic Study Identifies More Than 100 Variants Linked to Glaucoma
Helen Albert
-
February 25, 2021
0
Related Content
Personalis Lands Tempus as Partner to Co-Commercialize Its MRD Test in Lung and Breast Cancer
Early Coronary Heart Disease Can Increase Later Dementia Risk
Personalized Strategies Can Improve Dementia Risk
Alzheimer’s Diagnosis Delayed for Many Black Patients
Inside Precision Medicine
![Epic Sciences said today its liquid biopsy blood test showed in a study that it can help physicians select prostate cancer patients who are likely to benefit from a Pfizer prostate-specific membrane antigen (PSMA)-targeted therapy candidate known as BIND-014 before the start of treatment. [Source: © Alex Tihonov/Fotolia]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1907.jpeg "Novel Biomarker Could Aid Development of Drugs for Age-Related Disorders")
